March 2004

The 5% Shuffle – How not to get funded

March 30, 2004

The 5% Shuffle – How not to get funded Before you go ahead and pitch your potential to capture some percentage of a market, read this article. Bottom line: market’s aren’t captured, spending budgets are. Focus on capturing your customer’s budgets, not the “market.” Share this page

Read the full article →

A Drug Behemoth In The Making?

March 23, 2004

A Drug Behemoth In The Making? “Novartis plus Aventis would create the world’s No. 2 drugmaker, unless politics get in the way “

Read the full article →

Is genetic engineering next doping threat?

March 22, 2004

Is genetic engineering next doping threat? Experts worry that biotechnology could infiltrate sports

Read the full article →

Boy May Force Change in Norway Bio-Ethics Law

March 19, 2004

Boy May Force Change in Norway Bio-Ethics Law “A campaign to save a six-year-old Norwegian boy with a life-threatening blood disorder looked likely Thursday to force Norway to relax strict biotechnology laws in a stinging defeat for the government. “

Read the full article →

Drug Prices: The Genentech Solution

March 18, 2004

Drug Prices: The Genentech Solution “If developed nations want access to breakthrough medicines, they should have to pay full price, says Genentech Chief Executive Arthur D. Levinson. “

Read the full article →

Amgen Opens The Secret Curtain

March 18, 2004

Amgen Opens The Secret Curtain “The biotech leader will host analysts and investors to drum up excitement for its pipeline — and its stock. Will it work? “

Read the full article →

Biotech uptick moves into March

March 8, 2004

Biotech uptick moves into March: “February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, [...]

Read the full article →

And When ImClone’s Drug Doesn’t Work…

March 3, 2004

And When ImClone’s Drug Doesn’t Work… It’s not all roses for Erbitux: “The drug dramatically shrinks colon tumors in some patients. But in others, it has little effect — and no one knows why. “

Read the full article →